WT1-CTL (Atara/MSKCC)

N/A

Report date: 2024/11/09 20:00:08

Base Information

Drug NameWT1-CTL (Atara/MSKCC)
Drug Alias NameWT1-CTL-Atara-MSKCCATA-520
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionWilms' Tumour 1 modulators
TargetsWilms' Tumour 1
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Sydney
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A